Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Efficacy of quantitative analysis of Epstein-Barr virus-infected peripheral blood lymphocytes by in situ hybridization of EBER1 after living-related liver transplantation: a case report.

Nakazawa Y, Chisuwa H, Ikegami T, Hashikura Y, Matsunami H, Ichikawa T, Oh-ishi T, Kawasaki S.

Transplantation. 1997 May 15;63(9):1363-6.

PMID:
9158036
2.

Application of in situ hybridization technique for quantitative assessment of ongoing symptomatic Epstein-Barr virus infection after living related liver transplantation.

Egawa H, Ohishi T, Arai T, Inomata Y, Uemoto S, Asonuma K, Kinchi T, Okajima H, Matsui A, Kawashima N, Martinez OM, Tanaka K.

Clin Transplant. 1998 Apr;12(2):116-22.

PMID:
9575399
3.

Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.

Meerbach A, Wutzler P, Häfer R, Zintl F, Gruhn B.

J Med Virol. 2008 Mar;80(3):441-54. doi: 10.1002/jmv.21096.

PMID:
18205222
5.

Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus.

Lones MA, Shintaku IP, Weiss LM, Thung SN, Nichols WS, Geller SA.

Hum Pathol. 1997 May;28(5):533-9.

PMID:
9158700
6.

Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.

McDiarmid SV, Jordan S, Kim GS, Toyoda M, Goss JA, Vargas JH, Martín MG, Bahar R, Maxfield AL, Ament ME, Busuttil RW.

Transplantation. 1998 Dec 27;66(12):1604-11. Erratum in: Transplantation 1999 Sep 27;68(6):909. Lee GS [corrected to Kim GS].

PMID:
9884246
7.

Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation.

Raymond E, Tricottet V, Samuel D, Reynès M, Bismuth H, Misset JL.

Cancer. 1995 Oct 15;76(8):1344-51. Review.

8.
9.

Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.

Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.

Ann Hematol. 2006 Jul;85(7):478-84. Epub 2006 Apr 4.

PMID:
16586109
10.

Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease.

Smets F, Latinne D, Bazin H, Reding R, Otte JB, Buts JP, Sokal EM.

Transplantation. 2002 May 27;73(10):1603-10.

PMID:
12042647
11.

Significance of serial real-time PCR monitoring of EBV genome load in living donor liver transplantation.

Matsukura T, Yokoi A, Egawa H, Kudo T, Kawashima M, Hirata Y, Tanaka H, Kagajo K, Wada H, Tanaka K.

Clin Transplant. 2002 Apr;16(2):107-12.

PMID:
11966780
13.

Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease.

Green M, Cacciarelli TV, Mazariegos GV, Sigurdsson L, Qu L, Rowe DT, Reyes J.

Transplantation. 1998 Dec 27;66(12):1641-4.

PMID:
9884252
14.

Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome.

Holmes RD, Orban-Eller K, Karrer FR, Rowe DT, Narkewicz MR, Sokol RJ.

Transplantation. 2002 Aug 15;74(3):367-72.

PMID:
12177616
15.

Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: three-year experience.

Rogers BB, Sommerauer J, Quan A, Timmons CF, Dawson DB, Scheuermann RH, Krisher K, Atkins C.

Pediatr Dev Pathol. 1998 Nov-Dec;1(6):480-6.

PMID:
9724334
16.

Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children.

Green M, Bueno J, Rowe D, Mazariegos G, Qu L, Abu-Almagd K, Reyes J.

Transplantation. 2000 Aug 27;70(4):593-6.

PMID:
10972215
17.

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients.

Stevens SJ, Verschuuren EA, Pronk I, van Der Bij W, Harmsen MC, The TH, Meijer CJ, van Den Brule AJ, Middeldorp JM.

Blood. 2001 Mar 1;97(5):1165-71.

18.

Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.

Gustafsson A, Levitsky V, Zou JZ, Frisan T, Dalianis T, Ljungman P, Ringden O, Winiarski J, Ernberg I, Masucci MG.

Blood. 2000 Feb 1;95(3):807-14.

20.

Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.

Clave E, Agbalika F, Bajzik V, Peffault de Latour R, Trillard M, Rabian C, Scieux C, Devergie A, Socié G, Ribaud P, Adès L, Ferry C, Gluckman E, Charron D, Esperou H, Toubert A, Moins-Teisserenc H.

Transplantation. 2004 Jan 15;77(1):76-84.

PMID:
14724439

Supplemental Content

Support Center